TD Asset Management Portfolio holdings
AUM
$117B
1-Year Return
25.17%
This Quarter Return
+3.51%
1 Year Return
+25.17%
3 Year Return
+87.06%
5 Year Return
+156.45%
10 Year Return
+305.53%
AUM
$65.6B
AUM Growth
+$303M
(+0.46%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
28.73%
Holding
1,484
New
144
Increased
569
Reduced
642
Closed
73
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
$199M |
| 2 |
iShares Russell 2000 ETF
IWM
|
$167M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$149M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
$120M |
| 5 |
Technology Select Sector SPDR Fund
XLK
|
$105M |
Top Sells
| 1 |
Comcast
CMCSA
|
$140M |
| 2 |
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
|
$140M |
| 3 |
Royal Bank of Canada
RY
|
$135M |
| 4 |
Toronto Dominion Bank
TD
|
$124M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
$99.2M |
Sector Composition
| 1 | Financials | 29.07% |
| 2 | Energy | 12.31% |
| 3 | Industrials | 9.79% |
| 4 | Technology | 9.36% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Heartland Express
HTLD
$666M
| $404K | ﹤0.01% |
+21,800
| New | +$404K |
|
|
MRTX
1302
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $404K | ﹤0.01% |
8,200
+200
| +3% | +$9.85K |
|
1303
Rocket Pharmaceuticals
RCKT
$354M
| $402K | ﹤0.01% |
20,495
+300
| +1% | +$5.88K |
|
1304
Fate Therapeutics
FATE
$116M
| $401K | ﹤0.01% |
35,400
-6,200
| -15% | -$70.2K |
|
1305
BrightView Holdings
BV
$1.36B
| $400K | ﹤0.01% |
+18,246
| New | +$400K |
|
1306
La-Z-Boy
LZB
$1.49B
| $398K | ﹤0.01% |
+13,000
| New | +$398K |
|
1307
Zai Lab
ZLAB
$3.42B
| $398K | ﹤0.01% |
17,100
+200
| +1% | +$4.66K |
|
1308
Itaú Unibanco
ITUB
$76.6B
| $397K | ﹤0.01% |
76,505
-2,368
| -3% | -$12.3K |
|
1309
PennyMac Financial
PFSI
$6.08B
| $397K | ﹤0.01% |
20,200
+200
| +1% | +$3.93K |
|
1310
Vanguard Total World Stock ETF
VT
$51.8B
| $393K | ﹤0.01% |
6,455
| – | – |
|
|
CS
1311
DELISTED
Credit Suisse Group
CS
| $390K | ﹤0.01% |
26,236
+650
| +3% | +$9.66K |
|
1312
LeMaitre Vascular
LMAT
$2.21B
| $388K | ﹤0.01% |
+11,600
| New | +$388K |
|
|
FPRX
1313
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $388K | ﹤0.01% |
24,529
+300
| +1% | +$4.75K |
|
|
QVCGA
1314
QVC Group, Inc. Series A Common Stock
QVCGA
$73.3M
| $387K | ﹤0.01% |
375
-5
| -1% | -$5.16K |
|
1315
Hawkins
HWKN
$3.49B
| $385K | ﹤0.01% |
+21,800
| New | +$385K |
|
|
ISCA
1316
DELISTED
International Speedway Corp
ISCA
| $381K | ﹤0.01% |
8,516
+500
| +6% | +$22.4K |
|
1317
Federated Hermes
FHI
$4.1B
| $380K | ﹤0.01% |
16,296
-1,108
| -6% | -$25.8K |
|
|
MDP
1318
DELISTED
Meredith Corporation
MDP
| $379K | ﹤0.01% |
7,426
-418
| -5% | -$21.3K |
|
1319
Origin Bancorp
OBK
$1.21B
| $374K | ﹤0.01% |
+9,131
| New | +$374K |
|
1320
Trustmark
TRMK
$2.43B
| $374K | ﹤0.01% |
11,452
-690
| -6% | -$22.5K |
|
|
TVRD
1321
Tvardi Therapeutics, Inc. Common Stock
TVRD
$292M
| $372K | ﹤0.01% |
539
+6
| +1% | +$4.14K |
|
|
TUP
1322
DELISTED
Tupperware Brands Corporation
TUP
| $370K | ﹤0.01% |
8,978
-504
| -5% | -$20.8K |
|
1323
Assembly Biosciences
ASMB
$183M
| $369K | ﹤0.01% |
783
+133
| +20% | +$62.7K |
|
1324
Zillow
Z
$21.3B
| $368K | ﹤0.01% |
6,224
-20,000
| -76% | -$1.18M |
|
1325
Goosehead Insurance
GSHD
$2.11B
| $367K | ﹤0.01% |
+14,694
| New | +$367K |
|